Clinical Trial Update: A Study of TLC590 for Postsurgical Pain Following Bunionectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for TLC590 in postoperative pain after bunionectomy; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• TLC590

Snippet

Sponsor: TLC Biopharmaceuticals, Inc. | Conditions: Postoperative Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING